Voyager Therapeutics Inc. logo

Voyager Therapeutics Inc.

VYGR | NASDAQ
Chart Builder DCF Calculator
$3.10
+$0.02 (+0.65%)
Sep 22, 2026, 11:11 AM ET · Market open

Market Data

Market Cap
$186.1M
Enterprise Value
$102.33M
Beta
1.32
Average Volume
580.91K
Shares Outstanding (Diluted)
60.55M
Shares Change YoY
3.21%
Institutional Ownership
56.34%
Exchange
NASDAQ
ISIN
US92915B1061

Price Performance

Price Change 1M
-9.4%
Price Change 3M
-16.8%
Price Change 6M
-23.6%
Price Change YTD
-23.6%
Price Change 1Y
-27.0%
Price Change 3Y
-59.5%
Price Change 5Y
4.8%
1M CAGR (ann.)
-5.8%
1Y CAGR (ann.)
-31.4%
5Y CAGR (ann.)
-1.3%
All-Time CAGR
-14.9%

Valuation

PE Ratio
-1.70
Forward PE
N/A
PEG Ratio
0.96
Forward PEG
0.07
PS Ratio
5.40
Forward PS
4.00
PB Ratio
1.21
P/FCF Ratio
-1.20
P/Adj. FCF Ratio
-1.10
P/OCF Ratio
-1.55
EV/Sales
2.97
EV/EBIT
-0.95
EV/EBITDA
-0.99
EV/FCF
-0.66
Earnings Yield
-58.8%
FCF Yield
-83.2%
Adj. FCF Yield
-90.9%

Financial Health

Net Cash
$83.77M
Total Debt
$32.57M
Cash & Short-Term Investments
$116.34M
Total Assets
$197.75M
Current Ratio
7.51
Quick Ratio
7.51
Debt / Equity Ratio
0.21
Debt / EBITDA
-0.32
Debt / FCF
-0.21
OCF / Debt
-4.73
Interest Coverage
0.00
Altman Z-Score
-1.92
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
-104.2%
Operating Profit Margin
-340.1%
EBITDA Margin
-298.5%
Net Profit Margin
-312.6%
FCF Margin
-449.4%
Adj. FCF Margin
-491.1%
SBC / Revenue
34.5%
SBC Impact (per share)
-9.3%

Returns

Return on Assets
-54.5%
Return on Equity
-57.9%
Return on Invested Capital
-62.4%
Return on Capital Employed
-64.7%
Return on Tangible Assets
-54.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
-43.9%
Revenue CAGR 5Y
-23.6%
Revenue CAGR 10Y
6.5%
EPS CAGR 3Y
-92.8%
EPS CAGR 5Y
-85.8%
EPS CAGR 10Y
17.4%
FCF CAGR 3Y
-67.9%
FCF CAGR 5Y
-133.0%
FCF CAGR 10Y
-17.9%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
21
EPS Growth Next 3Y
19.5%
Revenue Growth Next 3Y
47.3%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.41
EPS Growth Est (next Q)
-12.8%
Revenue Est (next Q)
$6.35M
Revenue Growth Est (next Q)
-52.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$14.40
Price Target Upside
367.5%

Cash Flow

Operating Cash Flow
$-153.99M
Free Cash Flow
$-154.85M
Adj. Free Cash Flow
$-169.24M
FCF Per Share
-$2.01
OCF Per Share
-$1.99
OCF/S Ratio
-349.9%

Income Statement

Revenue
$34.46M
Gross Profit
$-35.89M
Operating Income
$-117.19M
EBITDA
$-102.85M
Net Income
$-107.73M
EPS (Diluted)
-$1.81
Revenue / Employee
$244.39K
Profit / Employee
$-764.03K
Employees
141

© 2026 bestshares.com. All rights reserved.